Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;30(3):234-46.
doi: 10.4274/Tjh.2012.0192. Epub 2013 Sep 5.

Quality of life and supportive care in multiple myeloma

Affiliations
Review

Quality of life and supportive care in multiple myeloma

Melda Cömert et al. Turk J Haematol. 2013 Sep.

Abstract

Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival.

Conflict of interest: None declared.

Multipl miyelom en sık görülen ikinci hematolojik malignitedir. Yeni tedaviler sağkalımda iyileşme sağlamıştır. Günümüzde uygulanan miyelom tedavi yönetimi, hastalığı kontrol altına alarak sağkalımda iyileşme sağlarken etkili destekleyici tedavi ile de yaşam kalitesini artırmaktadır. Destekleyici tedavi, hastaların yaşam kalitesini artırması ve sağkalımı iyileştirmesi nedeni ile miyelom hastalarının tedavi yönetiminin önemli bir parçasıdır. Bu derlemenin amacı yaşam kalitesi, destekleyici tedavi ve sağkalımdaki iyileşme arasındaki ilişkiyi vurgulamaktır.

Keywords: Multiple myeloma; Quality of life; Supportive care.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Wong-Baker facial grimace pain scale

References

    1. Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105:1684–1692. - PMC - PubMed
    1. Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111:2521–2526. - PubMed
    1. Brenner H, Gondos A, Pulte D. Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010. Haematologica. 2009;94:270–275. - PMC - PubMed
    1. Wagner LI, Robinson D, Jr, Weiss M, Katz M, Greipp P, Fonseca R, Cella D. Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. J Pain Symptom Manage. 2012;43:1094–1103. - PMC - PubMed
    1. Etto LY, Morelli VM, Silva VC, Hungria VT, Ciconelli RM, Almeida MS, Oliveira JS, Barros JC, Durie BG, Colleoni GW. Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients. Clinics. 2011;66:1855–1859. - PMC - PubMed

LinkOut - more resources